Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 8
2005 5
2006 5
2007 5
2008 4
2009 13
2010 9
2011 5
2012 5
2013 6
2014 7
2015 4
2016 1
2017 8
2018 4
2019 5
2020 5
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondrial Protection by PARP Inhibition.
Gallyas F Jr, Sumegi B. Gallyas F Jr, et al. Among authors: sumegi b. Int J Mol Sci. 2020 Apr 16;21(8):2767. doi: 10.3390/ijms21082767. Int J Mol Sci. 2020. PMID: 32316192 Free PMC article. Review.
PARP inhibition and postinfarction myocardial remodeling.
Halmosi R, Deres L, Gal R, Eros K, Sumegi B, Toth K. Halmosi R, et al. Among authors: sumegi b. Int J Cardiol. 2016 Aug;217 Suppl:S52-9. doi: 10.1016/j.ijcard.2016.06.223. Epub 2016 Jun 28. Int J Cardiol. 2016. PMID: 27392900 Review.
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.
Berger NA, Besson VC, Boulares AH, Bürkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL, Haskó G, Liaudet L, Moroni F, Pacher P, Radermacher P, Salzman AL, Snyder SH, Soriano FG, Strosznajder RP, Sümegi B, Swanson RA, Szabo C. Berger NA, et al. Among authors: sumegi b. Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Br J Pharmacol. 2018. PMID: 28213892 Free PMC article. Review.
[Mitochondria, oxidative stress and aging].
Szarka A, Bánhegyi G, Sümegi B. Szarka A, et al. Among authors: sumegi b. Orv Hetil. 2014 Mar 23;155(12):447-52. doi: 10.1556/OH.2014.29852. Orv Hetil. 2014. PMID: 24631932 Review. Hungarian.
Hydroximic acid derivatives: pleiotropic HSP co-inducers restoring homeostasis and robustness.
Crul T, Toth N, Piotto S, Literati-Nagy P, Tory K, Haldimann P, Kalmar B, Greensmith L, Torok Z, Balogh G, Gombos I, Campana F, Concilio S, Gallyas F, Nagy G, Berente Z, Gungor B, Peter M, Glatz A, Hunya A, Literati-Nagy Z, Vigh L Jr, Hoogstra-Berends F, Heeres A, Kuipers I, Loen L, Seerden JP, Zhang D, Meijering RA, Henning RH, Brundel BJ, Kampinga HH, Koranyi L, Szilvassy Z, Mandl J, Sumegi B, Febbraio MA, Horvath I, Hooper PL, Vigh L. Crul T, et al. Among authors: sumegi b. Curr Pharm Des. 2013;19(3):309-46. doi: 10.2174/138161213804143716. Curr Pharm Des. 2013. PMID: 22920902 Review.
Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases.
Szabo A, Sumegi K, Fekete K, Hocsak E, Debreceni B, Setalo G Jr, Kovacs K, Deres L, Kengyel A, Kovacs D, Mandl J, Nyitrai M, Febbraio MA, Gallyas F Jr, Sumegi B. Szabo A, et al. Among authors: sumegi b. Biochem Pharmacol. 2018 Apr;150:86-96. doi: 10.1016/j.bcp.2018.01.038. Epub 2018 Feb 3. Biochem Pharmacol. 2018. PMID: 29378182 Free article.
98 results